Crystal structure of FM329, a recombinant Fab adopted from cetuximab
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| C | Ig_3 | e5gz0C1 | A: a/b three-layered sandwiches | X: TIM beta/alpha-barrel | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: Ig_3 | ECOD (v294.1) |
| A | Ig_3 | e5gz0A1 | A: a/b three-layered sandwiches | X: TIM beta/alpha-barrel | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: Ig_3 | ECOD (v294.1) |
| D | Ig_3 | e5gz0D1 | A: a/b three-layered sandwiches | X: TIM beta/alpha-barrel | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: Ig_3 | ECOD (v294.1) |
| B | Ig_3 | e5gz0B1 | A: a/b three-layered sandwiches | X: TIM beta/alpha-barrel | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: Ig_3 | ECOD (v294.1) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| | Fab FM329 | L-KAPPA | Homo sapiens (human) | IGKV5-48*01, IGKJ5*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202611-0) |
| | Fab FM329 | VH-CH1 | Homo sapiens (human) | IGHV2-2*03, IGHJ3*01, IGHG1*03 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202611-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Light Chain | IGKV5 | Kappa | - | SAbDab (2026-03-27) |
| | Heavy Chain | IGHV2 | - | - | SAbDab (2026-03-27) |
| Chain | Name | Target | Provenance Source |
|---|
| Izalontamab | EGFR/ERBB1/HER1, ERBB3/HER3 | Therapeutic SAbDab (2026-03-27) |
| Cetuximab | EGFR/ERBB1/HER1, ERBB3/HER3 | Therapeutic SAbDab (2026-03-27) |